New eczema cream given green light by NICE

Credit: Bacsica

By Storm Newton, PA

More than 62,000 people in England with debilitating hand eczema could benefit from a new treatment that has been given the go-ahead to be rolled out on the NHS.

The recommendation for delgocitinib, also known as Anzupgo and made by Leo Pharma, could also save the NHS millions of pounds, according to NICE.